Amrutha Pattamatta

Title: Amrutha Pattamatta: Innovator in Genetic Research

Introduction

Amrutha Pattamatta is a notable inventor based in Watertown, MA (US). She has made significant contributions to the field of genetic research, particularly in the modulation of gene expression related to neurodegenerative diseases. Her work is crucial for developing therapeutic strategies for conditions such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

Latest Patents

Amrutha holds 1 patent titled "Modulators of chromosome 9 open reading frame 72 gene expression and uses thereof." This patent provides compositions and methods for modulating the transcription of mutant C9orf72 gene alleles in patients suffering from C9orf72-related diseases. The implications of her research are profound, as they offer potential pathways for treatment in affected individuals.

Career Highlights

Amrutha is currently employed at Sangamo Therapeutics, Inc., where she continues her innovative work in genetic therapies. Her role at the company allows her to collaborate with other experts in the field, enhancing the impact of her research.

Collaborations

Some of her notable coworkers include Joseph F Nabhan and Mohammad Samie. Their collaborative efforts contribute to the advancement of genetic research and the development of new therapeutic approaches.

Conclusion

Amrutha Pattamatta is a pioneering inventor whose work in gene modulation holds promise for treating serious neurodegenerative diseases. Her contributions to the field are invaluable and continue to inspire future innovations in genetic research.